Article Text
PDF
Abstract
Objective This study aimed to assess the economic efficiency of the acute medical unit (AMU) hospitalist care model, utilising patient outcomes (length of hospital stay, emergency department (ED)-length of hospital stay, in-hospital mortality) from a previous investigation.
Design A retrospective cohort study was conducted using benefit–cost analysis from a societal perspective. Data relating to clinical factors, outcomes and medical costs were obtained from the electronic medical record database at our institution. Literature-based costing was applied to determine direct non-medical costs and indirect costs that could not be obtained directly.
Setting A tertiary care hospital in the Republic of Korea.
Participants We evaluated 6391 medical inpatients admitted through the ED from 1 June 2016 to 31 May 2017.
Interventions The study compared multiple types of costs and benefits among inpatients from the ED between a non-hospitalist group and an AMU hospitalist group.
Results
This investigation found a significant reduction in medical costs and total costs in the AMU hospitalist group compared to the non-hospitalist group (30% reduction, 95% CI: 27.6–32.1%, P=0.000; 29.3% reduction, 95% CI: 27.0–31.5%, P=0.000; respectively). Furthermore, significant reductions in direct and indirect costs were found in the AMU hospitalist group compared to the non-hospitalist group (28.6% reduction, 95% CI: 26.6–30.5%, P=0.000; 23.3% reduction, 95% CI: 20.9–25.5%, P=0.000; respectively). The net-benefit and benefit-cost ratio (BCR) of the AMU hospitalist care group were US $6846 and 1.33 per patient admission, respectively.
Conclusions The AMU hospitalist care model was associated with remarkable reductions in multiple costs. The results of the sensitivity analysis indicated that the net-benefit estimates of AMU hospitalist care were similar to the baseline estimates. Thus, the overall net-benefit of AMU hospitalist care was found to be largely positive.
- Health Services
- Health economics
- Health policy
- Health & safety
- Safety
- PUBLIC HEALTH
Data availability statement
Data are available upon reasonable request. Data are available from the corresponding author upon reasonable request.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
STRENGTHS AND LIMITATIONS OF THIS STUDY
In this study, extensive cost analysis was conducted from a societal perspective.
The study encompassed all medical inpatients who were admitted from the emergency department to medical wards throughout the specified time frame from 1 June 2016 to 31 May 2017. Having such broad inclusion criteria is likely to have enhanced the validity of the findings.
Making generalisations regarding this retrospective study is challenging because of its singular institution of origin.
Expenditures apart from medical costs were not obtained directly but were calculated after consulting relevant sources; therefore, a degree of uncertainty may remain in the cost estimates.
This study could not quantify the potential benefits associated with a reduction in admissions to the intensive care unit. Therefore, the benefits determined in this study may have been undervalued.
Introduction
In South Korea, a pilot hospitalist care system was implemented from 2016 to address reduced numbers of medical personnel and improve the quality of inpatient care.1 The pilot project was integrated within the general hospital care system after 5 years, and the number of hospitalists in Korea has increased to approximately 250.2 Under the hospitalist care model, a dedicated specialist takes comprehensive responsibility directly and provides managed care to patients during admission, whereas under the non-hospitalist care model, a resident provides care to patients during admission under the supervision of a specialist.
Since the implementation of the hospitalist care system in Korea, research on patient outcomes has been conducted3–9 in terms of in-hospital mortality (IHM), intensive care unit (ICU) admission, emergency department-length of stay (ED-LOS) and total length of hospital stay (LOS). Although there have been many studies on the effectiveness of the hospitalist system, few studies have been undertaken on costs or involving economic evaluations. While some studies have reported on the medical costs of hospitalist care in South Korea,7 10 no economic evaluations from a societal perspective have been reported concerning hospitalist care in South Korea. Therefore, evaluating the economic efficiency of hospitalist care is necessary, considering both its costs and effects in terms of whether it is efficient within the overall medical system. In this study, economic efficiency was defined by a positive net-benefit and benefit–cost ratio (BCR) exceeding 1. Hence, we conducted an economic evaluation that accounted for both costs and benefits for the same patient population whose outcomes had been previously assessed.9
In this study, a societal-perspective economic evaluation was conducted to estimate the overall costs and benefits of the acute medical unit (AMU) hospitalist care model implemented at our institution, based on patient outcomes. We aimed to provide new evidence on the economic efficiency of the AMU hospitalist care model.
Methods
Study participants and AMU setting
We evaluated 6391 medical inpatients admitted through the emergency department (ED) of our institution from 1 June 2016 to 31 May 2017, who were assigned to AMU hospitalist care and non-hospitalist care groups (2426 and 3965 patients, respectively). The AMU patients were evaluated and treated by four hospitalists with an average of 10 years of clinical experience in infectious diseases, pulmonology and critical care, nephrology and endocrinology.9 Seven days per week, two AMU hospitalists were responsible for the care of the AMU patients admitted during the day. In addition, non-hospitalist inpatient care was provided by subspecialists and residents in a specialty medical ward, where residents were primarily responsible for inpatient care under the supervision of an attending physician.9 While hospitalist care in the AMU focused on general acute care, non-hospitalist care in the specialty medical ward emphasised long-term and specialised treatment.9
Study design
This retrospective cohort study compared and analysed the cost-saving benefits, calculated based on costs and patient outcomes, between AMU hospitalist care and non-hospitalist care groups for patients admitted through the ED at a tertiary hospital.
We conducted a benefit–cost analysis and divided costs into medical costs, non-medical costs and time costs in terms of productivity loss.11 This investigation was conducted in accordance with Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022).12 A flow diagram of the study population and benefit–cost factors is presented in online supplemental 1.
Supplemental material
Outcomes and clinical variables
Outcomes and clinical variables were obtained from the electronic medical records (EMRs) at our institution. Among the outcome variables, IHM, LOS and ED-LOS were used to calculate costs and benefits as well as the time cost of productivity loss. Productivity loss is the time cost incurred as a result of mortality or disease-related restrictions on productive activities due to admission.13
We analysed the following clinical variables of the participants: age, sex, prior hospitalisation history, cardiopulmonary resuscitation (CPR) incidence, cause of ICU admission, referral to a specialty, consultations, surgical intervention (cases performed during the hospitalisation, not before), major diagnosis (based on the International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM))), Korean Triage and Acuity Scale (KTAS), Age-adjusted Charlson Comorbidity Index (ACCI) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores. The ACCI score is derived from the sum of 1, 2, 3 and 6 weighted values for 17 disease groups, ranging from 0 to 29; higher scores indicate higher severity.14 The KTAS, which is currently applied in emergency medical centres in Korea, is a national standardised classification tool for evaluating illness severity.15 We used the APACHE II score to compare the disease severity among ICU admissions; this score (range: 0–71) has been found to closely correlate with the risk of hospital death.16 Baseline characteristics of the study population are presented in table 1.9
Baseline characteristics of patients cared for by hospitalists and non-hospitalists (N=6391)
Cost measures
Micro-costing and gross-costing were used for cost calculation in this study. Micro-costing was applied to directly calculate the medical costs during the total hospital stay.17 Gross-costing was used to calculate all costs other than medical costs (online supplemental 2). The costs were classified into direct costs and indirect costs,13 with all unit costs converted to United States (US) dollars as of 2023.
Supplemental material
Direct costs
Direct costs comprised medical costs (micro-costing), family caregiver transportation fares, paid care costs and doctor labour costs in hospitalisation (gross-costing). Healthcare in South Korea is a single-payer system organised through the National Health Insurance Service (NHIS). Nearly all citizens receive universal medical care through this system.18 The governance of National Health Insurance in South Korea is presented in online supplemental 3. The health security system in Korea has two components: mandatory social health insurance and medical aid. In Korea, fee-for-service has been the standard payment model for outpatient care and the majority of inpatient care, leading to an increase in the volume of services that healthcare professionals can provide.19 Medical costs in this study comprised reimbursements issued to medical providers by the NHIS and co-payments paid to medical providers by patients.
Supplemental material
Medical cost data were obtained from hospital administrative information in the EMRs at our institution regarding consultation fee, admission fee (mainly hospital room expense, including for isolation, intensive care and general hospital room), medication fee (medication/injection/anaesthesia/whole blood and blood product), treatment and surgery fee, medical examination fee (inspection/medical imaging/CT/MRI/positron emission tomography/ultrasonography), therapeutic materials and other factors (prosthetics, orthodontics/rehabilitation and physiotherapy/ psychotherapy).
The family caregiver transportation fare in relation to hospitalisation was estimated by multiplying referenced costs (2017 Korea Health Panel Study20 and the 2017 Consumer Price Index21) by individual patient’s LOS. The term ‘family caregiver transportation costs’ referred to the mean expenses for round-trip transportation for each visit of a family caregiver to a medical facility during the patient’s hospitalisation.20 The paid care cost was calculated by multiplying the referenced average costs22 by individual patient’s LOS. During the day, hospitalists administer care to patients in the hospitalist care group while residents provide care under the direction of a subspecialist. During the night, residents care for patients in both groups. The daytime doctor labour costs were estimated and analysed separately for residents, subspecialists and hospitalists (online supplemental files 2 and 4). Resident doctor labour costs per patient were estimated using the following variables: the average after-tax salary (2017 resident training environment evaluation survey results23), four major social insurance scheme classifications (national pension, health insurance, employment insurance and workers’ compensation insurance24) and tax (income tax and resident tax25), the number of inpatients per physician26 and the total patient days (the total number of days for all inpatients) in the non-hospitalist care group. Subspecialist labour costs were calculated using a referenced average labour cost,27 the number of inpatients per physician28 29 and the total patient days in the non-hospitalist care group.
Supplemental material
The AMU hospitalist labour costs per patient were calculated using a referenced average labour cost,30 the number of AMU hospitalists and AMU-LOS in the hospitalist care group. In addition, doctor labour costs for night shifts were estimated by reflecting the number of patients under the charge of residents,31 residents’ average wage and total patient days in the non-hospitalist care group.
Indirect costs
Indirect costs (time costs) were calculated by applying the gross-costing method. Patient productivity loss during hospitalisation (time costs) was calculated by multiplying the average daily wage by gender and age,32 by individual LOS and by the labour force participation rate.33 Family caregiver productivity loss was calculated by multiplying the average daily wage of all workers32 by individual LOS. Patient productivity loss due to ED-LOS was calculated by multiplying the average hourly wage by gender and age,32 by individual ED-LOS and by the labour force participation rate.33 Patient productivity loss due to death in hospitalisation was calculated by multiplying the average annual wage by gender and age,32 by the labour force participation rate33 and by individual life years gained in relation to death.34 Individual life years gained were estimated by subtracting life expectancy reduced by major diseases from life expectancy by gender and age, in reference to life tables available from the Korean Statistical Information Service (KOSIS, 2017).34
Benefit measure
In this study, the human capital approach was used as a method of evaluating the value of ‘health’ or ‘life’ in monetary units.17 Benefits, in the form of cost savings, were then estimated based on direct and indirect costs.
Economic evaluation: benefit–cost analysis
In benefit–cost analysis, the BCR and net-benefit are used as indicators for decision indices. Net-benefit refers to the benefit minus the cost, with a larger net-benefit indicating a more favourable benefit–cost situation.17 Therefore, we used BCR and net-benefit as indicators in terms of decision indices.
Sensitivity analysis
This study is a retrospective study of costs incurred. As the study period comprised only 1 year, a discount rate was not applied to the costs and a sensitivity analysis was performed on uncertain variables.35 The results of the sensitivity analysis are presented in a tornado diagram (figure 1).
One-way sensitivity analysis for the length of hospital stay, emergency department-length of stay and paid care costs. Supplementary Materials: online supplemental 1: Flow diagram of the study population and benefit–cost factors; online supplemental 2: Type of costs, cost estimation formula and data source; online supplemental 3: Governance of National Health Insurance in South Korea; online supplemental 4: Doctor labour cost estimation by patient flow and timeline; online supplemental 5: Cost analysis for urgent and non-urgent cases treated by hospitalists or non-hospitalists (N=6391); online supplemental 6: Cost analysis for patients with different comorbidity severities treated by hospitalists or non-hospitalists (N=6391); online supplemental 7: Cost analysis according to major diseases between hospitalist and non-hospitalist groups (N=6391); online supplemental 8: Cost analysis according to age between hospitalist and non-hospitalist groups (N=6391); online supplemental 9: Natural log-transformed multivariable regression analysis for medical costs and total costs (N=6391); online supplemental 10: Natural log-transformed multivariable regression analysis for direct costs and indirect costs (N=6391); online supplemental 11: One-way sensitivity analysis for resident labour costs; online supplemental 12: One-way sensitivity analysis for hospitalist labour costs; online supplemental 13: One-way sensitivity analysis for specialist labour costs; online supplemental file 14: Two-way sensitivity analysis for hospitalist and resident labour costs; online supplemental 15: Two-way sensitivity analysis for hospitalist and specialist labour costs.
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
First, a sensitivity analysis was conducted on LOS and ED-LOS, which showed a skewed distribution. We analysed the 1%-trimmed mean by calculating the average of the remaining values while excluding some (1%) from the extremes of the data.
Second, a sensitivity analysis was conducted on paid care costs among the direct non-medical costs that were considered to have high uncertainty. Assuming that no caregiver was hired, the baseline paid care costs were set at $53,22 and the maximum daily paid care costs for hospitalised patients were set at $122.22
Third, a sensitivity analysis was conducted on doctor labour costs among the direct non-medical costs that were considered to have high uncertainty, with both one-way and two-way sensitivity analyses conducted. Resident labour costs were set at $44 180 as a baseline, with a minimum value of $37 350 and a maximum value of $52,669.23 Hospitalist and specialist labour costs were set at $115 452 as a baseline,27 30 with a minimum value of $76 458 and a maximum value of $152 917.
Statistical analysis
Categorical variables are reported as percentages and continuous variables as mean±SD. Groups were compared by conducting Pearson’s χ2 tests or t-tests, as appropriate. ACCI, LOS and ED-LOS were expressed as the median and IQR. For these variables, groups were compared by conducting the Mann-Whitney U test, owing to their skewed distributions. We performed subgroup analyses of costs and benefits according to age, the severity of the patient’s condition (based on the KTAS score), the degree of comorbidity (based on the ACCI score) and the major disease category (based on the ICD-10). Natural log-transformed multivariable regression analysis was conducted in relation to the costs. As the unit cost was large, using a natural logarithm can increase normality and enable accurate values to be obtained during analysis as well as reduce skewness and kurtosis of the data. Regression analysis for the costs was used to adjust for the following factors: age, sex, prior hospitalisation, referral to specialty, consultation, CPR, KTAS score, ACCI score, surgical intervention, major disease, ICU admission, IHM, LOS and ED-LOS. Using the estimates from the regression models, we presented differences between AMU hospitalised and non-hospitalised groups in terms of medical, direct, indirect, and total costs.
Patient and public involvement
This was a non-interventional study conducted retrospectively. Consequently, no patients participated directly in the study’s conception, formulation of research objectives and queries, or execution. In addition, patients were not involved in the interpretation of results or production of the manuscript. It is not currently in our intentions to disseminate the findings to the study participants.
Results
Costs
All costs are presented as costs per patient admission in this study. The estimated costs 36 between the hospitalist group and the non-hospitalist group are presented in table 2. The total costs were significantly lower in the hospitalist group than in the non-hospitalist group, with a difference of more than $6000 (20570±91024 vs 27416±102360, p=0.007). The direct medical costs were significantly lower in the hospitalist group than in the non-hospitalist group, with a difference of more than $900 (4075±6504 vs 5050±7255, p=0.000).
Costs of patients cared for by hospitalists and non-hospitalists (N=6391)
Among the subcategories of medical costs, the biggest difference was found in relation to the admission fee and medical examination fee (886±1661 vs 1167±1697, p=0.003; 1269±1629 vs 1565±1676, p=0.000; respectively). Among the direct non-medical costs, the family caregiver transportation fare, paid care costs and doctor labour costs were significantly lower in the hospitalist group than in the non-hospitalist group (p=0.007, p=0.007 and p=0.000; respectively).
The indirect costs were significantly lower in the hospitalist group than in the non-hospitalist group, with a difference of more than $5000 (14988±89 375 vs 20719±1 00 689, p=0.021). Among the indirect costs, family caregiver productivity loss according to LOS and patient productivity loss according to ED-LOS and IHM were significantly lower in the hospitalist group than in the non-hospitalist group (p=0.007, p=0.000 and p=0.023, respectively). However, there were no significant differences between the two groups in terms of patient productivity loss according to LOS (560±782 vs 549±788, p=0.570).
Subgroup cost differences according to KTAS scores, comorbidity severity, major disease and age
Cost analysis was performed according to subgroups of patients stratified by KTAS scores, ACCI scores, major disease and age to determine differences between the two groups (online supplemental 5–8). Compared with the non-hospitalist group, the hospitalist group’s overall costs for more urgent cases were significantly reduced by more than $8000 (p=0.002). In low-to-moderate comorbidity groups (ACCI=0–2, 3 and 4 points), there was a greater cost reduction in the hospitalist group than in the non-hospitalist group ($12941, p=0.033; $10017, p=0.152; $8199, p=0.016; respectively).
Among the major diseases, in all but three disease types, the overall cost in the hospitalist group decreased compared with the non-hospitalist group (online supplemental 7). In a subgroup analysis by age, total costs in the hospitalist group decreased in almost all age groups (p=0.248, p=0.004, p=0.000, p=0.002, p=0.001, respectively).
Natural log-transformed multivariable regression analysis of costs
We performed natural log-transformed multivariable regression analysis to adjust for clinical variables and outcome variables potentially associated with costs, namely, medical, direct, indirect and total costs (online supplemental 9 and 10). Regression analysis revealed a significant 30% reduction in medical costs and a 29.3% reduction in total costs in the hospitalist group compared with the non-hospitalist group (e−0.355=0.701, p=0.000; e−0.346=0.707, p=0.000; respectively). Furthermore, there was a significant reduction of 28.6% in direct costs and a 23.3% reduction in indirect costs in the hospitalist group compared with the non-hospitalist group (e−0.336=0.714, p=0.000; e−0.265=0.767, p=0.000; respectively).
Benefit–cost analysis
Net-benefit and BCR analysis were conducted according to the total group and subgroups of patients stratified by clinical variables, KTAS scores, ACCI scores, major diagnoses and age (table 3). Among the total group of patients, the net-benefit and BCR of the AMU hospitalist care group were $6846 and 1.33 per patient admission, respectively; overall net-benefit of AMU hospitalist care was found to be largely positive. Among the patients stratified by clinical variables, net-benefit and BCR of AMU hospitalist care were found to be largely positive in all but five subgroups (less urgent; ACCI ≥5; diseases of the circulatory system; diseases of the genitourinary system and endocrine, nutritional and metabolic diseases).
Benefit–cost analysis
Sensitivity analysis
The sensitivity analysis results for LOS and ED-LOS are shown in figure 1A,B. We analysed the 1%-trimmed mean and excluded patients with extreme values, as noted. After excluding extreme values related to LOS, the results were stable (net-benefit: $7162 to $8067, BCR: 1.31 to 1.33) and showed no significant difference from the baseline analysis. Sensitivity analysis for ED-LOS revealed that the results were similar to (net-benefit: $6311 to $6846, BCR: 1.31 to 1.33) the baseline analysis. After varying paid care costs from $0 to $122, the sensitivity analysis results were stable, with the net-benefit ranging from $8013 to $8138 and the BCR from 1.32 to 1.34 (figure 1C). One-way sensitivity analysis results showed comparative values of resident, specialist and hospitalist labour costs (online supplemental 11–13), with resident labour costs ranging from $37 350 to $52,669, which indicated a net-benefit ranging from $6841 to $6851 (BCR, 1.33) (online supplemental 11). After varying specialist labour costs from $76 458 to $152,917, the results were similar to baseline estimates, with net-benefit ranging from $6764 to $6924 (BCR, 1.33) (online supplemental 12).
After varying hospitalist labour costs from $76 458 to $152,917, the results were stable, with the net-benefit ranging from $6784 to $6910 (BCR, 1.33) (online supplemental 13).
Two-way sensitivity analysis results on hospitalist and resident labour costs showed that net-benefit ranged from $6779 to $6916 and BCR from 1.33 to 1.34 (online supplemental 14). Moreover, two-way sensitivity analysis results on hospitalist and specialist labour costs showed that net-benefit ranged from $6703 to $6988 and BCR from 1.33 to 1.34 (online supplemental 15).
Discussion
Study summary
This study is the first to report on the economic efficiency of a Korean AMU hospitalist care model while controlling for clinical factors. We found a notable cost reduction with AMU hospitalist care compared with non-hospitalist care in all areas: medical costs, direct costs, indirect costs and total costs. In this study, medical costs included hospitalist care fees. The same trend towards cost reduction was observed in the subgroup and regression analyses. In this study, the cost of doctor labour was estimated separately for each hospitalisation flow and day and night shifts (online supplemental 4).
The net-benefit and BCR analysis results of the AMU hospitalist care group were $6846 and 1.33 per patient admission, respectively; overall, the net-benefit of AMU hospitalist care was found to be largely positive. Sensitivity analysis showed that the net-benefit and BCR results of AMU hospitalist care were similar to baseline analysis.
In the present resident training system, which lacks a structured curriculum, training has taken the form of encountering more patients and accumulating experience over time. Many institutions still use the apprenticeship model of training to become specialists. The Medical Resident Act has been enacted to address this issue; however, the situation remains ambiguous in the field.37 Moreover, residents who rotate annually or monthly will inevitably experience strained relationships with other professional teams, and medical treatment is frequently interrupted due to complications such as doctor–nurse disputes.2 However, direct, real-time communication among our multidisciplinary team members, which enables appropriate and quick decision-making on treatments for patients with acute diseases, is a key component of our AMU care.3
Furthermore, consultation, formulation and implementation of treatment plans and the treatment itself are responsibilities shared among residents, fellows and attending specialists in the context of resident/attending specialist care. However, hospitalists carry the sole responsibility for all these tasks.38 Moreover, hospitalists have extensive knowledge and proficiency in managing patients who are hospitalised. Their level of professionalism is unparalleled compared with that of residents with 1–2 years of experience, as evidenced by their critical thinking skills, patient communication capabilities and accountability for treatment.38 Consequently, these characteristics are believed to help reduce overall costs, including medical costs.
Furthermore, our previous study reported that AMU hospitalist care improved patient outcomes in terms of IHM, ICU admission rate, LOS and ED-LOS.9 This enhanced performance may have led to a reduction in indirect expenses and productivity loss.
Direct medical costs
Some previous studies that investigated the costs of hospitalist care have reported reduced medical costs in hospitalist care.10 39–46 In contrast, other studies have reported no significant difference in total medical costs between patients treated by hospitalists and those treated by non-hospitalists7 47 and that the costs of care for hospitalists were more than those for specialists but less than those for generalists.48 Our study showed that there was a marked cost reduction in consultation, admission, treatment and surgery, medical examination and therapeutic materials fees among the medical cost subcategories. Even when hospitalist care fees were included in medical costs, the hospitalist group’s medical costs were lower, which indicates that the difference would be even greater if hospitalist care fees were excluded. Among the previous studies, one study that evaluated Korean hospitalists reported that medical costs reduced by $208 in terms of hospitalist care.10 However, in our study, medical expenses per admission decreased by nearly $1000 in the hospitalist care group. Both research findings regarding medical cost reduction are comparable, but our study’s findings on cost-reduction suggest a more substantial reduction is involved.
The patient group in our study consisted of patients with acute medical conditions admitted through the ED of a tertiary general hospital, with their disease severity being higher than that among those in the total group of patients, which may explain the difference in study results. However, the regression analyses showed a significant 30% reduction in medical costs in the hospitalist group after adjusting for clinical factors. Despite the conflicting results reported in earlier studies, our research findings offer compelling evidence supporting the effectiveness of the AMU hospitalist care model in reducing medical costs.
Direct non-medical costs compared with indirect costs
Studies are lacking on the economic implications of hospitalist care from a societal perspective. Hence, we conducted an estimation and analysis of non-medical expenses to assess the economic feasibility of AMU hospitalist care from a societal perspective.
In a previous study, we reported that AMU hospitalist care considerably improved patient outcomes in terms of IHM, ICU admission rate, LOS and ED-LOS.9 In this study, we used patient outcomes from that study to estimate the following costs: family caregiver transportation fares in hospitalisation, paid care costs in hospitalisation, patient productivity loss based on LOS, family caregiver productivity loss based on LOS, patient productivity loss based on ED-LOS and patient productivity loss based on IHM.
The hospitalist care group’s decreased LOS resulted in a notable reduction in expenses related to family caregiver transportation and paid care during patient hospitalisation.
With the exception of patient productivity loss based on LOS, substantial reductions in expenses were shown for family caregiver productivity loss based on LOS and patient productivity loss based on ED-LOS and IHM. The hospitalist group exhibited a considerably reduced LOS in comparison to the non-hospitalist group.9 However, it is possible that the lower age of the patients in the hospitalist group may account for the larger patient productivity loss based on the LOS observed in this group. Nevertheless, AMU hospitalist care resulted in notable reductions in the indirect costs, surpassing $7000 in savings when compared with the non-hospitalist group. This improvement in patient outcomes played a pivotal role in achieving these cost reductions. Therefore, the overall costs in relation to the AMU hospitalist care group showed a notable decrease in comparison to the non-hospitalist group.
Benefit–cost analysis
The net-benefit and BCR analysis of the AMU hospitalist care group yielded results of $6846 and 1.33 per patient admission, respectively, indicating that the overall net-benefit of AMU hospitalist care was found to be largely positive. However, variations in net-benefit and BCR analysis ranges were seen across different subgroups (-$10 604 to $52948, 0.41 to 5.23; respectively). This indicates that the economic efficacy of AMU hospitalist care varies based on the clinical characteristics of patients. Nevertheless, in terms of net-benefit and BCR results, the overall net-benefit of AMU hospitalist care was found to be largely positive in 17 subgroups and negative in five subgroups (less urgent; ACCI ≥5; diseases of the circulatory system; diseases of the genitourinary system; and endocrine, nutritional and metabolic diseases). It is possible that this population has a greater demand for specialised care; furthermore, treatment modalities and expenses can vary substantially based on the reason for admission even for the same disease. In our study, clinical variables were adjusted for factors such as age, severity, the major disease and KTAS. To determine the precise reason for the negative results reported in these five groups, more research into the variables leading to hospitalisation or disease-specific clinical outcomes is required.
These findings might potentially serve as a valuable reference for the development of a more efficient hospitalist care paradigm in further research.
A one-way sensitivity analysis was conducted to examine the impact of variations in the LOS, ED-LOS, paid care costs and doctor labour costs. The net-benefit and BCR analysis results of AMU hospitalist care were stable based on a one-way sensitivity analysis using these four variables. The results of a two-way sensitivity analysis indicated that the net-benefit and BCR results of AMU hospitalist care were similar to the baseline estimates despite fluctuations in labour costs for the resident, specialist and hospitalist.
Limitations
This study had some limitations. First, it employed a retrospective design, which posed challenges in mitigating the effect of confounding factors and discerning whether the observed results were attributable to the AMU environment or the treatment administered by the hospitalists. Second, the study was conducted at a single site, which limits the extent to which our findings may be generalised. Third, other expenditures, excluding medical expenses, were not directly obtained but rather calculated by consulting relevant sources, which introduced a degree of uncertainty into the cost estimations. Fourth, the present study could not provide a quantifiable assessment of the potential benefits associated with the reduction of ICU admissions. Five, the value and benefits of teaching services were not evaluated in this study. Even if costs are higher for teaching services than for non-teaching services, training future physicians is a valuable goal. Hence, further investigation to ascertain the value and benefits of teaching services from a societal perspective is required.
Conclusion
This study showed that AMU hospitalist care significantly reduced costs in nearly all categories, including medical costs, direct costs, indirect costs and total costs. Moreover, in the benefit–cost analysis, the net-benefit and BCR results of the AMU hospitalist care group were shown to be greater than $6000 and 1.30 per patient admission, respectively. These results indicate that the overall net-benefit of AMU hospitalist care is largely positive. Nevertheless, further investigation is necessary to identify the factors that contribute to hospitalisation or disease-specific clinical outcomes.
Data availability statement
Data are available upon reasonable request. Data are available from the corresponding author upon reasonable request.
Ethics statements
Patient consent for publication
Ethics approval
Ethical approval was provided by the Institutional Review Board of Seoul National University Bundang Hospital (IRB Number B-1711/435-107). Our institution’s ethics committee waived the need for informed consent owing to the retrospective nature of the study and the use of anonymised data previously collected for routine clinical care.
Acknowledgments
We would like to thank Editage (www.editage.co.kr) for English language editing.
References
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Footnotes
Contributors Conceptualisation: HJK, JK, JHO, N-HK. Methodology: HJK, JK, JHO, N-HK. Software: HJK. Validation: HJK, JK, JHO, N-HK. Formal analysis: HJK. Investigation: HJK, JK, JHO, N-HK. Data curation: HJK. Writing—original draft: HJK. Writing—review and editing: HJK, JK, JHO, N-HK. All authors have read and approved the final draft of the manuscript. JK is the guarantor.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Not commissioned; externally peer-reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.